CELLICON VALLEY
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

CELLICON VALLEY Trademark

Serial Number: 97522048

CELLICON VALLEY is a trademark filed by CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC on July 27, 2022. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC (19 trademarks)

411 SWEDELAND ROAD
KING OF PRUSSIA, PA 19406

Entity Type: 16

Trademark Details

Filing Date

July 27, 2022

Registration Date

Not Registered

Published for Opposition

May 16, 2023

Goods & Services

Manufacturing services for others in the fields of pharmaceutical preparations, biopharmaceutical preparations, biologics, drug products, DNA plasmids, advanced therapeutic medicinal products (ATMPs), principally cell and gene therapies intended for research, clinical and commercial use in humans for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting; production of cell lines for others using lentivirus technology

Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy

Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services in the field of production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and ยท manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 12, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 12, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 21, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 17, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 17, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 17, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 11, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2022 NWOS
NEW APPLICATION ENTERED
Jul 30, 2022 NWAP